Russia announced this Tuesday, August 11, having developed the first vaccine against the coronavirus. An announcement made by the Russian president himself, Vladimir Putin.
Following this announcement, the World Health Organization (WHO) reacted cautiously recalling that the “pre -qualification” and the approval of a vaccine passed through “rigorous” procedures.
This coronavirus vaccine was baptized “Spoutnik V”, in reference to the Soviet satellite, the first spacecraft put in orbit.
The Nikolai Gamaleïa Institute, the National Research Center for Epidemiology, received product development authorization after clinical trials started less than two months ago in humans.
The Deputy Prime Minister in charge of health issues, Tatiana Golikova, said he wanted to start vaccination of the nursing staff in the coming weeks, while phase 3 of the trials must start this week to determine the safety and efficiency of the product. The circulation of large -scale vaccine is estimated at January 2021 according to the national Russian medication register.
Moreover, “more than a billion doses” have been pre-ordered by 20 foreign countries, said the president of the sovereign fund, Kirill Dmitriev, involved in his development.
Russian Minister of Health, Mikhail Murachko, taken up by the RIA Novosti agency, for its part, added that technical regulations are being developed for large -scale production on the sites of a certain number of national representatives, however no serious complications have been noted during the various test phases.
